Friday, 31 August 2018

AstraZeneca's Lupus Treatment Misses Goal in Final-Stage Study



from Bloomberg https://ift.tt/2N5lc8k

No comments:

Post a Comment

A risky corner of the ETF market has boomed this year as YOLO traders chase the rally

A fund that tracks Nvidia stock is one of the most popular leveraged ETFs. Slaven Vlasic/Getty Images for The New York Times; Chelsea Jia F...